Residual Neuromuscular Blockade in Cardiac Surgery Patients

• Status: Unknown status
• Trial end date: 2019-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this project is to determine if reversal of neuromuscular blockade in cardiac surgery patients expedites time to extubation in fast track patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Henry Ford Health System
• Treatments: Glycopyrrolate; Neostigmine

Criteria

Inclusion Criteria:

• All outpatients >18 years of age scheduled for elective coronary artery bypass graft surgery (CABG), aortic valve replacement (AVR), or combination CABG/AVR

Exclusion Criteria:

• Chronic kidney disease stage IV or V

• Liver disease, defined as AST, ALT or ALP > 1.5x upper limit of normal Inpatient status

• Allergy to rocuronium